Related Experiment Videos
Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism
C Papin1, A Denouel-Galy, D Laugier
1Unité Mixte de Recherche 146 du CNRS, Institut Curie, Centre Universitaire, Laboratoire 110, 91405 Orsay Cédex, France.
Abstract:
Members of the raf oncogene family encode serine/threonine protein kinases, which activate the mitogen-activated protein kinase kinase MEKs (MAPK or ERK kinases) through direct interaction and phosphorylation. Several recent studies have revealed interesting differences between two members of this family, Raf-1 and B-Raf, regarding their activation, regulation, and kinase activity. In particular, B-Raf was shown to display higher MEK kinase activity than Raf-1. By using both two-hybrid analysis and coimmunoprecipitation experiments, we demonstrate here that B-Raf also markedly differs from Raf-1 by a higher affinity for MEK. We previously reported that the B-raf gene encodes multiple protein isoforms resulting from complex alternative splicing of two exons (exons 8b and 10) located upstream of B-Raf kinase domain. In the present study, we show that these naturally occurring modifications within the protein sequence markedly modulate both the biochemical and oncogenic properties of B-Raf. The presence of exon 10 sequences enhances the affinity for MEK, the basal kinase activity, as well as the mitogenic and transforming properties of full-length B-Raf, whereas the presence of exon 8b sequences seems to have opposite effects. Therefore, alternative splicing represents a novel regulatory mechanism for a protein of the Raf family.
Insights
B-Raf exhibits higher MEK affinity and kinase activity than Raf-1. Alternative splicing of B-Raf exons 8b and 10 significantly alters its biochemical and oncogenic properties, revealing a novel regulatory mechanism.
Area of Science:
- Molecular Biology
- Oncogenesis
- Signal Transduction
Background:
- The Raf oncogene family encodes serine/threonine kinases crucial for mitogen-activated protein kinase (MAPK) pathway activation.
- B-Raf and Raf-1, members of this family, display distinct activation, regulation, and kinase activities.
- B-Raf has demonstrated higher MEK kinase activity compared to Raf-1.
Purpose of the Study:
- To investigate the differences in MEK binding affinity between B-Raf and Raf-1.
- To explore the impact of alternative splicing in the B-raf gene on protein function.
- To elucidate the role of specific exons (8b and 10) in modulating B-Raf's biochemical and oncogenic properties.
Main Methods:
- Two-hybrid analysis to assess protein-protein interactions.
- Coimmunoprecipitation experiments to confirm B-Raf and MEK binding.
- Biochemical assays to measure kinase activity and protein properties.
Main Results:
- B-Raf demonstrates a significantly higher affinity for MEK compared to Raf-1.
- Alternative splicing of B-raf, specifically involving exons 8b and 10, modulates B-Raf's biochemical and oncogenic characteristics.
- Exon 10 inclusion enhances MEK affinity, kinase activity, and mitogenic/transforming potential, while exon 8b inclusion appears to have opposing effects.
Conclusions:
- B-Raf's heightened affinity for MEK contributes to its distinct biological functions.
- Alternative splicing of the B-raf gene serves as a novel regulatory mechanism, fine-tuning the kinase's activity and oncogenic potential.
- Understanding these alternative splicing events is critical for comprehending Raf-mediated signaling in cancer.